| __timestamp | Amphastar Pharmaceuticals, Inc. | Celldex Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 210461000 | 3586000 |
| Thursday, January 1, 2015 | 251519000 | 5480000 |
| Friday, January 1, 2016 | 255165000 | 6786000 |
| Sunday, January 1, 2017 | 240175000 | 12743000 |
| Monday, January 1, 2018 | 294666000 | 9538000 |
| Tuesday, January 1, 2019 | 322357000 | 3573000 |
| Wednesday, January 1, 2020 | 349846000 | 7418000 |
| Friday, January 1, 2021 | 437768000 | 4651000 |
| Saturday, January 1, 2022 | 498987000 | 2357000 |
| Sunday, January 1, 2023 | 644395000 | 6883000 |
Infusing magic into the data realm
In the dynamic world of biopharmaceuticals, understanding revenue trends is crucial for investors and stakeholders. Amphastar Pharmaceuticals, Inc. and Celldex Therapeutics, Inc. present a fascinating case study. From 2014 to 2023, Amphastar's revenue surged by over 200%, peaking in 2023 with a remarkable $644 million. This growth reflects their strategic expansion and successful product launches. In contrast, Celldex's revenue remained relatively stable, with a modest increase of around 92% over the same period, reaching approximately $6.9 million in 2023. This disparity highlights the varied strategies and market positions of these companies. Amphastar's consistent upward trajectory underscores its robust market presence, while Celldex's steady performance suggests a focus on niche markets. As the biopharmaceutical landscape evolves, these trends offer valuable insights into the competitive dynamics and future potential of these industry players.
Breaking Down Revenue Trends: Novo Nordisk A/S vs Celldex Therapeutics, Inc.
Revenue Insights: Pfizer Inc. and Amphastar Pharmaceuticals, Inc. Performance Compared
Regeneron Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc.: Examining Key Revenue Metrics
GSK plc vs Amphastar Pharmaceuticals, Inc.: Examining Key Revenue Metrics
Bio-Techne Corporation vs Amphastar Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Who Generates More Revenue? Sarepta Therapeutics, Inc. or Celldex Therapeutics, Inc.
Walgreens Boots Alliance, Inc. and Amphastar Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Exelixis, Inc. vs Amphastar Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Telix Pharmaceuticals Limited and Amphastar Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
TG Therapeutics, Inc. vs Amphastar Pharmaceuticals, Inc.: Annual Revenue Growth Compared
ACADIA Pharmaceuticals Inc. and Celldex Therapeutics, Inc.: A Comprehensive Revenue Analysis
Revenue Insights: Celldex Therapeutics, Inc. and Viridian Therapeutics, Inc. Performance Compared